Država: Singapur
Jezik: engleski
Izvor: HSA (Health Sciences Authority)
Ceftriaxone Sodium 2.158g eqv to Ceftriaxone
LOTUS INTERNATIONAL PTE. LTD.
J01DD04
2.0 g
INJECTION, POWDER, FOR SOLUTION
Ceftriaxone Sodium 2.158g eqv to Ceftriaxone 2.0 g
INTRAVENOUS, INTRAMUSCULAR
Prescription Only
Sinopharm Zhijun (Shenzhen) Pharmaceutical Co., Ltd
ACTIVE
2014-11-20
1 Package Insert _ _ 1. NAME OF THE MEDICINAL PRODUCT CEFTRIAXONE ALVOGEN POWDER FOR SOLUTION FOR INJECTION/ INFUSION 1G/VIAL CEFTRIAXONE ALVOGEN POWDER FOR SOLUTION FOR INJECTION/ INFUSION 2G/VIAL 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains 1 g ceftriaxone (as ceftriaxone sodium). Each vial contains 2 g ceftriaxone (as ceftriaxone sodium). 3. PHARMACEUTICAL FORM Powder for solution for injection/infusion. Almost white or yellowish, slightly hygroscopic, crystalline powder. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Ceftriaxone is indicated for the treatment of the following infections when known or likely to be due to one or more susceptible micro-organisms (see section 5.1) and when parenteral therapy is required: - Pneumonia. - Sepsis. - Meningitis. - Bone, skin and soft tissue infections. - Infections in neutropenic patients. - Gonorrhoea. - Peri-operative prophylaxis of infections. Treatment may be started before the results of susceptibility tests are known. Consideration should be given to official guidance on the appropriate use of antibacterials. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology CEFTRIAXONE ALVOGEN may be administered by intramuscular injection, intravenous injection, or as intravenous infusion, after reconstitution of the solution according to the directions given below. Do not use diluents containing calcium, such as Ringer’s solution or Hartmann’s solution, to reconstitute ceftriaxone vials or to further dilute a reconstituted vial for IV administration because a precipitate can form. Precipitation of ceftriaxone-calcium can also occur when ceftriaxone is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone must not be administered simultaneously with calcium-containing IV solutions, including continuous calcium- containing infusions such as parenteral nutrition via a Y-site. However, in patients other than neonates, ceftriaxone and calcium-containing solutions may be administered sequentially of one another if the in Pročitajte cijeli dokument